Impaired dendritic cell proinflammatory cytokine production in psoriatic arthritis

Arthritis and Rheumatism

Volumn 63, Issue 11, 2011, Pages 3313-3322

  Wenink, Mark H ^a   Santegoets, Kim C M ^a   Butcher, John ^b   Van Bon, Lenny ^a   Lamers Karnebeek, Femke G M ^a   Van Den Berg, Wim B ^a   Van Riel, Piet L C M ^a   McInnes, Iain B ^b   Radstake, Timothy R D J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR 2;

ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MYCOBACTERIUM PARATUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS;

EID: 80155130052     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30577     Document Type: Article

References (49)

1. Ritchlin CT,. From skin to bone: translational perspectives on psoriatic disease. J Rheumatol 2008; 35: 1434-7. (Pubitemid 352000800)
2. McCarey D, McInnes IB,. Psoriatic arthritis: current topics. Curr Rheumatol Rep 2007; 9: 442-8. (Pubitemid 350305200)
3. Reich K, Kruger K, Mossner R, Augustin M,. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 2009; 160: 1040-7.
4. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009; 361: 496-509.
5. Curran SA, FitzGerald OM, Costello PJ, Selby JM, Kane DJ, Bresnihan B, et al. Nucleotide sequencing of psoriatic arthritis tissue before and during methotrexate administration reveals a complex inflammatory T cell infiltrate with very few clones exhibiting features that suggest they drive the inflammatory process by recognizing autoantigens. J Immunol 2004; 172: 1935-44. (Pubitemid 38116844)
6. De Cid R, Riveira-Munoz E, Zeeuwen PL, Robarge J, Liao W, Dannhauser EN, et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 2009; 41: 211-5.
7. Zeeuwen PL, de Jongh GJ, Rodijk-Olthuis D, Kamsteeg M, Verhoosel RM, van Rossum MM, et al. Genetically programmed differences in epidermal host defense between psoriasis and atopic dermatitis patients. PLoS One 2008; 3: e2301.
8. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-IκB pathways. Nat Genet 2009; 41: 199-204.
9. Kupper TS, Fuhlbrigge RC,. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 2004; 4: 211-22. (Pubitemid 38339087)
10. O'Neill LA,. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 2008; 226: 10-8.
11. Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, Tsui C, et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 2004; 5: 1052-60. (Pubitemid 41057725)
12. Hitotsumatsu O, Ahmad RC, Tavares R, Wang M, Philpott D, Turer EE, et al. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity 2008; 28: 381-90. (Pubitemid 351343859)
13. Noah PW, Handorf CR, Skinner RB Jr, Mandrell TD, Rosenberg EW,. Skin basement membrane zone: a depository for circulating microbial antigen evoking psoriasis and autoimmunity. Skinmed 2006; 5: 72-9.
14. Benjamin M, McGonagle D,. The enthesis organ concept and its relevance to the spondyloarthropathies. Adv Exp Med Biol 2009; 649: 57-70.
15. Moen K, Brun JG, Valen M, Skartveit L, Eribe EK, Olsen I, et al. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol 2006; 24: 656-63. (Pubitemid 46138797)
16. Vasey FB, Deitz C, Fenske NA, Germain BF, Espinoza LR,. Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis. J Rheumatol 1982; 9: 719-22. (Pubitemid 13169964)
17. Rahman MU, Ahmed S, Schumacher HR, Zeiger AR,. High levels of antipeptidoglycan antibodies in psoriatic and other seronegative arthritides. J Rheumatol 1990; 17: 621-5. (Pubitemid 20201738)
18. Lapadula G, Iannone F, Covelli M, Numo R, Pipitone V,. Anti-enterobacteria antibodies in psoriatic arthritis. Clin Exp Rheumatol 1992; 10: 461-6.
19. Rambukkana A, Das PK, Witkamp L, Yong S, Meinardi MM, Bos JD,. Antibodies to mycobacterial 65-kDa heat shock protein and other immunodominant antigens in patients with psoriasis. J Invest Dermatol 1993; 100: 87-92. (Pubitemid 23035911)
20. Dalbeth N, Yeoman S, Dockerty JL, Highton J, Robinson E, Tan PL, et al. A randomised placebo controlled trial of delipidated, deglycolipidated Mycobacterium vaccae as immunotherapy for psoriatic arthritis. Ann Rheum Dis 2004; 63: 718-22. (Pubitemid 38658403)
21. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24. (Pubitemid 18091653)
22. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, and the CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-73. (Pubitemid 44205029)
23. Rivas-Santiago B, Hernandez-Pando R, Carranza C, Juarez E, Contreras JL, Aguilar-Leon D, et al. Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells. Infect Immun 2008; 76: 935-41. (Pubitemid 351428052)
24. Yang CS, Shin DM, Kim KH, Lee ZW, Lee CH, Park SG, et al. NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression. J Immunol 2009; 182: 3696-705.
25. Yuk JM, Shin DM, Lee HM, Yang CS, Jin HS, Kim KK, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009; 6: 231-43.
26. Bowes J, Barton A,. The genetics of psoriatic arthritis: lessons from genome-wide association studies. Discov Med 2010; 10: 177-83.
27. Meier C, Plevy S,. Therapy insight: how the gut talks to the jointsâinflammatory bowel disease and the spondyloarthropathies. Nat Clin Pract Rheumatol 2007; 3: 667-74. (Pubitemid 350031756)
28. Makredes M, Robinson D Jr, Bala M, Kimball AB,. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis. J Am Acad Dermatol 2009; 61: 405-10.
29. Smith AM, Rahman FZ, Hayee B, Graham SJ, Marks DJ, Sewell GW, et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 2009; 206: 1883-97.
30. Zhang FR, Huang W, Chen SM, Sun LD, Liu H, Li Y, et al. Genomewide association study of leprosy. N Engl J Med 2009; 361: 2609-18.
31. Schurr E, Gros P,. A common genetic fingerprint in leprosy and Crohn's disease? N Engl J Med 2009; 361: 2666-8.
32. Bhambri S, Bhambri A, Del Rosso JQ,. Atypical mycobacterial cutaneous infections. Dermatol Clin 2009; 27: 63-73.
33. Cook GM, Berney M, Gebhard S, Heinemann M, Cox RA, Danilchanka O, et al. Physiology of mycobacteria. Adv Microb Physiol 2009; 55: 81-9.
34. Mueller P, Pieters J,. Modulation of macrophage antimicrobial mechanisms by pathogenic mycobacteria. Immunobiology 2006; 211: 549-56.
35. Mendoza JL, Lana R, Diaz-Rubio M,. Mycobacterium avium subspecies paratuberculosis and its relationship with Crohn's disease. World J Gastroenterol 2009; 15: 417-22.
36. Martineau AR, Wilkinson KA, Newton SM, Floto RA, Norman AW, Skolimowska K, et al. IFN-γ- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol 2007; 178: 7190-8. (Pubitemid 46847445)
37. Lee HM, Shin DM, Choi DK, Lee ZW, Kim KH, Yuk JM, et al. Innate immune responses to Mycobacterium ulcerans via Toll-like receptors and dectin-1 in human keratinocytes. Cell Microbiol 2009; 11: 678-92.
38. Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V, et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 2009; 206: 1983-94.
39. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007; 449: 564-9. (Pubitemid 47525141)
40. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007; 39: 207-11. (Pubitemid 46184351)
41. Lapaquette P, Glasser AL, Huett A, Xavier RJ, Darfeuille-Michaud A,. Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol 2010; 12: 99-113.
42. Huang J, Canadien V, Lam GY, Steinberg BE, Dinauer MC, Magalhaes MA, et al. Activation of antibacterial autophagy by NADPH oxidases. Proc Natl Acad Sci U S A 2009; 106: 6226-31.
43. Tubach F, Salmon D, Ravaud P, Allanore Y, Goupille P, Breban M, et al. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum 2009; 60: 1884-94.
44. Wenink MH, Santegoets KC, Broen JC, van Bon L, Abdollahi-Roodsaz S, Popa C, et al. TLR2 promotes Th2/Th17 responses via TLR4 and TLR7/8 by abrogating the type I IFN amplification loop. J Immunol 2009; 183: 6960-70.
45. Vazquez N, Greenwell-Wild T, Rekka S, Orenstein JM, Wahl SM,. Mycobacterium avium-induced SOCS contributes to resistance to IFN-γ-mediated mycobactericidal activity in human macrophages. J Leukoc Biol 2006; 80: 1136-44. (Pubitemid 44646319)
46. Jo EK,. Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs. Curr Opin Infect Dis 2008; 21: 279-86.
47. Kleinnijenhuis J, Joosten LA, van de Veerdonk FL, Savage N, van Crevel R, Kullberg BJ, et al. Transcriptional and inflammasome-mediated pathways for the induction of IL-1β production by Mycobacterium tuberculosis. Eur J Immunol 2009; 39: 1914-22.
48. Loof TG, Goldmann O, Medina E,. Immune recognition of Streptococcus pyogenes by dendritic cells. Infect Immun 2008; 76: 2785-92.
49. Schurr JR, Young E, Byrne P, Steele C, Shellito JE, Kolls JK,. Central role of Toll-like receptor 4 signaling and host defense in experimental pneumonia caused by Gram-negative bacteria. Infect Immun 2005; 73: 532-45. (Pubitemid 40041148)